rs80203202

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003922.4(HERC1):​c.3374G>A​(p.Gly1125Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0029 in 1,613,808 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0021 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 6 hom. )

Consequence

HERC1
NM_003922.4 missense

Scores

1
6
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:5

Conservation

PhyloP100: 7.24

Publications

7 publications found
Variant links:
Genes affected
HERC1 (HGNC:4867): (HECT and RLD domain containing E3 ubiquitin protein ligase family member 1) This gen encodes a member of the HERC protein family. This protein stimulates guanine nucleotide exchange on ARF1 and Rab proteins. This protein may be involved in membrane transport processes. [provided by RefSeq, Mar 2012]
HERC1 Gene-Disease associations (from GenCC):
  • macrocephaly, dysmorphic facies, and psychomotor retardation
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • megalencephaly-severe kyphoscoliosis-overgrowth syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.019063026).
BP6
Variant 15-63725486-C-T is Benign according to our data. Variant chr15-63725486-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 377238.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00211 (321/152164) while in subpopulation NFE AF = 0.00328 (223/68008). AF 95% confidence interval is 0.00293. There are 1 homozygotes in GnomAd4. There are 154 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 6 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HERC1NM_003922.4 linkc.3374G>A p.Gly1125Asp missense_variant Exon 18 of 78 ENST00000443617.7 NP_003913.3 Q15751A0A024R5W0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HERC1ENST00000443617.7 linkc.3374G>A p.Gly1125Asp missense_variant Exon 18 of 78 1 NM_003922.4 ENSP00000390158.2 Q15751
HERC1ENST00000561400.1 linkc.931-9013G>A intron_variant Intron 2 of 7 2 ENSP00000453937.1 H0YNB1

Frequencies

GnomAD3 genomes
AF:
0.00211
AC:
321
AN:
152046
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000556
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00328
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00205
AC:
510
AN:
248816
AF XY:
0.00202
show subpopulations
Gnomad AFR exome
AF:
0.000646
Gnomad AMR exome
AF:
0.00177
Gnomad ASJ exome
AF:
0.00677
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000557
Gnomad NFE exome
AF:
0.00285
Gnomad OTH exome
AF:
0.00265
GnomAD4 exome
AF:
0.00298
AC:
4356
AN:
1461644
Hom.:
6
Cov.:
31
AF XY:
0.00285
AC XY:
2069
AN XY:
727118
show subpopulations
African (AFR)
AF:
0.000597
AC:
20
AN:
33480
American (AMR)
AF:
0.00203
AC:
91
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00700
AC:
183
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000777
AC:
67
AN:
86256
European-Finnish (FIN)
AF:
0.000599
AC:
32
AN:
53402
Middle Eastern (MID)
AF:
0.00555
AC:
32
AN:
5768
European-Non Finnish (NFE)
AF:
0.00340
AC:
3784
AN:
1111810
Other (OTH)
AF:
0.00242
AC:
146
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.462
Heterozygous variant carriers
0
207
414
620
827
1034
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00211
AC:
321
AN:
152164
Hom.:
1
Cov.:
32
AF XY:
0.00207
AC XY:
154
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.000554
AC:
23
AN:
41510
American (AMR)
AF:
0.00183
AC:
28
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4816
European-Finnish (FIN)
AF:
0.000283
AC:
3
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00328
AC:
223
AN:
68008
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
19
37
56
74
93
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00278
Hom.:
3
Bravo
AF:
0.00218
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00493
AC:
19
ESP6500AA
AF:
0.000510
AC:
2
ESP6500EA
AF:
0.00302
AC:
25
ExAC
AF:
0.00210
AC:
254
EpiCase
AF:
0.00344
EpiControl
AF:
0.00385

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Dec 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HERC1: BS1 -

Oct 12, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 08, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Jul 20, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: HERC1 c.3374G>A (p.Gly1125Asp) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 248816 control chromosomes (gnomAD). c.3374G>A has been reported in the literature in individuals affected with schizophrenia (Mojarad_2021). These reports do not provide unequivocal conclusions about association of the variant with Macrocephaly, Dysmorphic Facies, And Psychomotor Retardation. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance and one ClinVar submitter (evaluation after 2014) cites it as likely benign. Based on the evidence outlined above, the variant was classified as uncertain significance. -

Macrocephaly, dysmorphic facies, and psychomotor retardation Uncertain:1
Sep 12, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 14, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

HERC1-related disorder Benign:1
Feb 23, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.11
T
Eigen
Uncertain
0.57
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.0052
T
MetaRNN
Benign
0.019
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.0
M
PhyloP100
7.2
PrimateAI
Uncertain
0.66
T
PROVEAN
Benign
0.010
N
REVEL
Benign
0.18
Sift
Benign
0.23
T
Sift4G
Benign
0.39
T
Polyphen
0.99
D
Vest4
0.85
MVP
0.15
MPC
0.43
ClinPred
0.033
T
GERP RS
5.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.13
gMVP
0.62
Mutation Taster
=58/42
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80203202; hg19: chr15-64017685; COSMIC: COSV101497135; COSMIC: COSV101497135; API